pentagastrin and Obesity, Morbid

pentagastrin has been researched along with Obesity, Morbid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baumgartner-Parzer, S; Bieglmayer, C; Hanslik, S; Kaserer, K; Niederle, B; Rondot, S; Schulze, E; Vierhapper, H; Wagner, L1
Johansson, C; Rössner, S; Wisén, O1

Other Studies

2 other study(ies) available for pentagastrin and Obesity, Morbid

ArticleYear
Primary hyperparathyroidism as the leading symptom in a patient with a Y791F RET mutation.
    Thyroid : official journal of the American Thyroid Association, 2005, Volume: 15, Issue:11

    Topics: Calcium; DNA Primers; Female; Humans; Hyperparathyroidism; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Mutation; Obesity, Morbid; Parathyroid Neoplasms; Parathyroidectomy; Pentagastrin; Proto-Oncogene Mas; Proto-Oncogene Proteins c-ret; Reverse Transcriptase Polymerase Chain Reaction

2005
Gastric secretion in massive obesity. Evidence for abnormal response to vagal stimulation.
    Digestive diseases and sciences, 1987, Volume: 32, Issue:9

    Topics: Blood Glucose; Fasting; Feeding Behavior; Female; Gastric Juice; Gastric Mucosa; Gastrins; Humans; Insulin; Obesity, Morbid; Pentagastrin; Vagus Nerve

1987